Pharma focus Cofactor Group specializes in consulting for pharmaceutical and biotechnology clients, indicating opportunities to offer strategic growth, regulatory navigation, market access, and R&D efficiency services to life sciences firms.

Mid-market scale With 11-50 employees and annual revenue between 25 and 50 million, Cofactor Group operates in a mid-market segment that may seek scalable, mentorship-driven consulting, process optimization, and technology-enabled solutions from more established firms.

Tech modern Current tech stack includes SAP, S/4HANA, Microsoft 365, PWA and related tools, suggesting opportunities to sell integration, data analytics, ERP optimization, and digital workflow solutions that align with their platform capabilities.

Growth potential The combination of strategic, medical/scientific expertise and analytics capability points to upsell opportunities in advanced analytics, performance benchmarking, and sustainability-focused growth planning for pharma/biotech clients.

Competitive landscape Operating alongside large, multi-billion revenue consultancies, Cofactor Group may benefit from targeted value propositions such as niche life sciences specialization, faster delivery, and flexible engagement models to capture mid-market pharma/biotech clients seeking boutique support.